{"id":"W2043470852","doi":"10.1371/journal.pone.0065569","title":"Novel Combination of Sorafenib and Celecoxib Provides Synergistic Anti-Proliferative and Pro-Apoptotic Effects in Human Liver Cancer Cells","year":2013,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôtel-Dieu de Québec; Université Laval; Centre hospitalier universitaire de Québec","funders":"Centre Hospitalier Universitaire de Québec; Ministero dell’Istruzione, dell’Università e della Ricerca","keywords":"Sorafenib; Cancer research; Cell cycle; Cell growth; Apoptosis; Celecoxib; Cancer cell; Liver cancer; Cell culture; Signal transduction; Biology; Transcriptome; Programmed cell death; Cancer; Pharmacology; Gene expression; Hepatocellular carcinoma; Gene; Cell biology; Biochemistry; Genetics","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001037508,0.0002989854,0.0005881327,0.0002873958,0.0001379709,0.0002279172,0.0001078251,0.0001420716,0.001069072],"category_scores_gemma":[0.00006266196,0.0001135116,0.0003011336,0.0002310028,0.0000789801,0.0001016016,0.0001194267,0.0002661237,0.0002697246],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001413108,"about_ca_system_score_gemma":0.0002261871,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004306343,"about_ca_topic_score_gemma":0.001080002,"domain_scores_codex":[0.9998518,0.00002349638,0.00001253527,0.00002574491,0.00005634242,0.00003006655],"domain_scores_gemma":[0.9999754,0.000003899782,0.000004683047,0.000002743887,0.000005364559,0.000007935158],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.000533638,0.00009885188,0.0003537143,0.0001055174,0.0000198074,0.00009660454,0.00001701753,0.0001159396,0.9919792,0.00003469637,0.000119445,0.006525419],"study_design_scores_gemma":[0.00009370673,0.001635421,0.008435115,0.000005389113,0.00007021523,0.0005712938,0.00003593145,0.001580672,0.9816057,0.00002679468,0.00593051,0.000009252597],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9905683,0.005210673,0.001729048,0.00009489714,0.00006906903,0.00005920122,0.0004400932,0.00008593976,0.001742816],"genre_scores_gemma":[0.9931638,0.001901642,0.001963073,0.00003988205,0.00002212167,0.0000604261,0.0008860831,0.000007408416,0.001955578],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001069072,"threshold_uncertainty_score":0.003576398,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02274846759049533,"score_gpt":0.2369083339074096,"score_spread":0.2141598663169142,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}